Objective-Current imaging modalities of atherosclerosis mainly visualize plaque morphology. Valuable insight into plaque biology was achieved by visualizing enhanced metabolism in plaque-derived macrophages using 18 Ffluorodeoxyglucose ( 18 F-FDG). Similarly, enhanced uptake of 18 F-fluorocholine ( 18 F-FCH) was associated with macrophages surrounding an abscess. As macrophages are important determinants of plaque vulnerability, we tested 18 F-FCH for plaque imaging. Methods and Results-We injected 18 F-FCH (nϭ5) or 18 F-FDG (nϭ5) intravenously into atherosclerotic apolipoprotein E-deficient mice. En face measurements of aortae isolated 20 minutes after 18 F-FCH injections demonstrated an excellent correlation between fat stainings and autoradiographies (rϭ0.842, PϽ0.0001), achieving a sensitivity of 84% to detect plaques by 18 F-FCH. In contrast, radiotracer uptake 20 minutes after 18 F-FDG injections correlated less with en face fat stainings (rϭ0.261, PϽ0.05), reaching a sensitivity of 64%. Histological analyses of cross-sections 20 minutes after coinjections of 18 F-FCH and 14 C-FDG (nϭ3) showed that 18 F-FCH uptake correlated better with fat staining (rϭ0.740, PϽ0.0001) and macrophage-positive areas (rϭ0.740, PϽ0.0001) than 14 Pϭ0.29 and CD68 staining: rϭ0.352, Pϭ0.11), respectively. Conclusions-18 F-FCH identifies murine plaques better than 18 F-FDG using ex vivo imaging. Enhanced 18 F-FCH uptake into macrophages may render this tracer a promising candidate for imaging plaques in patients. (Arterioscler Thromb Vasc Biol. 2006;26:584-589.)
C urrent clinical tools to image atherosclerotic plaques such as intravascular ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or optical coherence tomography (OCT) provide morphological images of the vessel wall at remarkable spatial resolution. [1] [2] [3] [4] However, these imaging modalities are unable to characterize details of plaque biology. More insight into plaque biology would be desirable to determine a better risk assessment of the vulnerable plaque. 5 The vulnerable plaque, because of its risk of rupturing, is considered the culprit lesion causing acute arterial obstruction, which may result in myocardial infarction or stroke.
Therefore, plaque imaging using molecular targets has gained increased attention. 6 For example, positron emission tomography (PET) provides attractive opportunities to visualize plaque biology. 7 Specifically, 18 F-fluorodeoxyglucose ( 18 F-FDG)-a widely used PET tracer-has been clinically used to image enhanced metabolism of cellular components of the plaque including macrophages. 8 Other studies have confirmed the relevance of 18 F-FDG for plaque imaging in Watanabe rabbits 9 and in patients with calcifications of the arterial wall 10 or active atherosclerosis. 11 These studies are of interest as macrophages play a crucial role in atherogenesis and, particularly, in plaque rupture. 12,13 18 F-labeled fluorocholine ( 18 F-FCH) has been introduced as a tracer for imaging brain and prostate cancer. 14, 15 Choline is taken up into cells by specific transport mechanisms, phosphorylated by choline kinase, metabolized to phosphatidylcholine, and eventually incorporated into the cell membrane. 16 -18 Increased choline uptake has been shown in tumor cells 19 and activated macrophages. 17 Based on this concept, we have recently demonstrated an enhanced 18 F-FCH uptake that correlated with macrophage accumulation as part of an inflammatory reaction after soft tissue infection 20 or acute cerebral radiation injury. 21 Therefore, we compared the ability of 18 F-FCH and 18 F-FDG to image murine atherosclerotic plaques ex vivo and validated these results against fat staining.
Materials and Methods
For more details, please see http://atvb.ahajournals.org.
Animals
Male atherosclerotic apolipoprotein E knockout (ApoE Ϫ/Ϫ , C57Bl/6J) mice 22 were fed a high-cholesterol diet (1.25% total cholesterol; RD12108; Research Diets) for 2 months starting at the age of 8 weeks. Animals were kept without food for 4 hours before injections of the radiotracers until sacrifice. A subset of wild-type C57Bl/6J mice without atherosclerosis received a normal chow diet. All animal experiments were performed in accordance with our institutional guidelines and approved by the local animal committee.
Radionuclides
Ex vivo plaque imaging was performed after injections of 18 F-FCH (45.8 to 60.5 MBq; nϭ5), 18 F-FDG (36.7 to 46.4 MBq; nϭ5), or coinjections of 18 F-FCH and 14 C-FDG (185kBq; nϭ3) in 300 L normal saline into the animals' tail veins.
Harvesting and Tissue Processing
For determining the uptake of 18 F-FCH, 18 F-FDG, or 14 C-FDG within plaques, ApoE Ϫ/Ϫ mice were euthanized 20 minutes after injection of the radiotracer(s); additional animals were euthanized 3 hours after 18 F-FDG injections. For en face analyses, distal aortae were opened longitudinally. For microscopic examinations, 3 samples of the proximal aorta were embedded in OCT compound (Tissue-Tek, Sakura, the Netherlands) and frozen in isopentane. Serial crosssections of 10 m thickness were immediately cut and thawmounted on glass slides. Autoradiography and fat stainings were performed on the same samples (nϭ12 from each animal). For biochemical analyses, aortae from ApoE Ϫ/Ϫ (nϭ3) and wild-type mice (nϭ3) were shock-frozen in liquid nitrogen (LN 2 ) and stored at Ϫ80°C.
Choline Kinase Activity and Expression
Plaque Imaging

Morphology
Plaque areas were assessed via fat staining using Oil-red O. Macrophages were identified on adjacent cross-sections using a rat antimouse CD68 monoclonal antibody (Serotec, Clone FA-II, 1:400).
Autoradiography
For en face macroautoradiography, aortae were longitudinally opened and exposed on a phosphor imaging screen with 14 C standards (for 4 hours with 18 F-labeling; for 10d using 14 C-labeling). Furthermore, aortic cross-sections of 10 m thickness were exposed with 14 C standards for microautoradiography. The data were scanned (Fuji BAS 1800 II; pixel size, 50 m) and converted to kBq/cc.
Signal Quantification
The lesion-to-nonlesion ratio in autoradiographies of longitudinally opened aortae was determined using linear integration of signal intensity (NIH Image J 1.33 software) over corresponding aortic areas taking the mean of 5 measurements from each animal. The corresponding ratio in 3 cross-sections of the proximal aorta was determined after injections of 18 F-FCH or 18 F-FDG by relating the signal intensity of a region of interest within the plaque to a region without lesion. In addition, the standardized uptake value (SUV) was obtained for each animal by dividing the target tissue radioactivity uptake (kBq/cc) within a region of interest by the injected activity per gram of body weight. Comparisons between en face fat stainings and corresponding autoradiographies were determined by converting the autoradiographies into color-coded images, tracing all positive areas (Analysis Five Docu, SoftImaging System) and correlating the percent positive of the total vessel areas using the Spearman rank correlation test (GraphPad Prism V4). Analogous comparisons were performed on 3 cross-sections of each animal in the proximal aorta after coinjections of 18 F-FCH and 14 C-FDG (nϭ3) for autoradiographies, fat, and CD68 stainings.
Mouse PET
For more detail, please see http://atvb.ahajournals.org.
Statistics
An unpaired t test was used to compare results between different groups. Values are given as meanϮSD; PϽ0.05 was considered statistically significant.
Results
F-FCH Macroscopically Visualizes Murine Atherosclerotic Plaques
En face analysis of atherosclerotic plaques revealed a strong and selective uptake of 18 F-FCH ( Figure 1A ). The mean signal-to-noise ratio of these macroautoradiographies relating radioactivity uptake in plaque-bearing to plaque-free vessel wall was 4.9Ϯ2.0 to 1 (nϭ5). Comparisons of the corresponding en face autoradiographic signals and fat stainings in single plaques demonstrated a highly significant correlation (rϭ0.842, PϽ0.0001) and a sensitivity of 84% to detect fat-stained areas by autoradiography. Because 18 F-FCH uptake in rodents and men reaches a plateau 20 minutes after radiotracer injection, 14, 15, 20, 21, 23 we did not study further time intervals for plaque imaging using 18 F-FCH.
F-FDG Visualizes Murine Plaques Less Specifically Than F-FCH
In light of previous reports with 18 F-FDG to image plaque biology in rabbits 9 and patients, 8, 10, 11 we validated the ability of 18 F-FDG to image murine atherosclerotic plaques applying the same experimental protocol as described for 18 F-FCH; 20 minutes after injection, 18 F-FDG uptake on autoradiography correlated poorly with the fat staining of plaques ( Figure 1B , top). The mean signal-to-noise ratio of radioactivity uptake in plaque-bearing versus plaque-free vessel wall was 6.0Ϯ5.1 to 1 (nϭ5). The sensitivity of the autoradiography after 18 F-FDG injection was only 64% to detect the fat-stained areas. Comparisons of the corresponding en face autoradiographic signals and fat stainings ( Figure 1B ) documented a lower correlation (rϭ0.261, PϽ0.05) than for 18 F-FCH.
Given the clinical report describing an interval of 3 hours as the optimal time course for 18 F-FDG imaging using PET-CT, 8 we investigated whether harvesting aortae 3 hours after intravenous 18 Table) than after 20 minutes. However, the mean signal-to-noise ratio of radioactivity uptake in plaque-bearing versus plaque-free vessel wall decreased to 2.6Ϯ0.9 to 1 (nϭ3). In addition, because of a high rate of 76% false-negative autoradiographic signals, the sensitivity of the autoradiography 3 hours after 18 F-FDG injection was only 57% to detect the fat-stained areas.
F-FCH Uptake Colocalizes With Plaques Using Microautoradiography
Analyses of cross-sections from the proximal aorta showed that 18 F-FCH uptake correlated well with plaques ( Figure  2A ), whereas 18 F-FDG uptake showed a lower sensitivity to identify atherosclerotic plaques ( Figure 2B ). The maximum of the SUV in the plaque was 1.8Ϯ1.0 for 18 F-FCH and 2.4Ϯ0.5 for 18 F-FDG (nϭ5; not significant [NS]). In addition, the signal-to-noise ratio (plaque-bearing vessel portion to plaque-free vessel wall) was 3.5Ϯ0.9 to 1 for 18 F-FCH and 2.9Ϯ0.5 to 1 for 18 F-FDG (NS).
F-FCH Uptake Colocalizes With Plaque Macrophages
Autoradiographic analyses of aortic cross-sections after intravenous coinjections of 18 F-FCH and 14 C-FDG into the same ApoE Ϫ/Ϫ mice showed similar radionuclide uptake in plaquebearing vessel areas ( Figure 3A , top; Table) . Under these conditions, the signal-to-noise ratio (lesion to nonlesion) calculated from the SUV was 2.5Ϯ0.4 to 1 for 18 F-FCH and 2.4Ϯ1.1 to 1 for 14 C-FDG (nϭ3; NS). Comparisons of single autoradiographic signals (20 minutes after coinjections of 18 F-FCH and 14 C-FDG), fat, and CD68 stainings in 3 cross-sections of atherosclerotic aortae; meanϮSD. Figure 3B , bottom), respectively.
Validation of 18 F-FCH or 14 C-FDG for Imaging Murine Plaques or Macrophages Ex Vivo in Cross-sections
F-FCH Mouse PET
Mouse PET scans obtained 10 to 30 minutes after 18 F-FCH injections could not detect a specific tracer uptake in atherosclerotic aortae of ApoE Ϫ/Ϫ mice but showed an increased unspecific 18 F-FCH uptake in metabolically active tissues such as heart and liver. Subsequent en face analyses of these aortae revealed a good colocalization of autoradiographies and fat stainings.
Choline Kinase Expression and Activity Are Unchanged in Atherosclerotic Versus Normal Aortae
As an increased choline uptake in tumor cells has been related to an upregulation of choline kinase and/or choline transport mechanisms, 17, 19 we compared expression and activity of choline kinase in atherosclerotic versus normal aortae isolated from ApoE Ϫ/Ϫ or wild-type mice, respectively. Both choline kinase expression and activity were similar. No methods are currently available for investigating choline transport in vivo.
Discussion
It is now well-recognized that plaque formation is a complex, noncontinuous process and that plaque rupture is not just a matter of size (ie, morphology), but mainly the consequence of plaque vulnerability (ie, biology). Thus, imaging of vulnerable plaques constitutes a great need in cardiovascular medicine. 5 In this study, we describe for the first time to our knowledge 18 F-FCH as a promising agent for imaging biological properties of murine atherosclerotic plaques using ex vivo macroautoradiography and microautoradiography. At the cellular level, uptake of 18 F-FCH correlated significantly with plaque macrophages. These findings extend our previous studies in which we described 18 F-FCH for noninvasive imaging of a soft tissue infection in a rat model. 20 Activated macrophages have been shown to play a key role in promoting atherogenesis. For example, by infiltrating the intimal layer, they replicate, become foam cells, and express and secrete hazardous inflammatory molecules within the arterial wall. Particularly, their formation of enzymes such as matrix metalloproteinases (MMPs) leads to thinning of the fibrous cap, thereby increasing the vulnerability of plaques. 12, 13 Enhanced 18 F-FDG uptake was recently reported in plaques of atherosclerotic rabbits 9 and humans. 8, 10, 11 Furthermore, increased 18 F-FDG uptake in unstable plaques colocalized with plaque macrophages, 8 suggesting increased metabolic activity. Thus, these authors proposed enhanced 18 F-FDG uptake in human plaques as a typical sign of plaque vulnerability. These reports and our previous findings inspired us to perform a side-by-side comparison of en face preparations 20 minutes after 18 F-FCH or 18 F-FDG injections complemented by cross-sections after simultaneous injections of 18 F-FCH and 14 C-FDG into ApoE Ϫ/Ϫ mice. As image acquisition 3 14 C-FDG into the same ApoE Ϫ/Ϫ mice were exposed over 4 hours ( 18 F-FCH uptake), then re-exposed for 10 days ( 14 C-FDG uptake) followed by fat staining. Anti-CD68 stainings identified macrophages in adjacent sections. Representative photomicrographs of cross-sections from 3 different animals are shown. The color calibration (right) indicates the SUV for 18 F-FCH or 14 C-FDG, respectively; barϭ500 m. B, Uptake of 18 F-FCH in cross-sections (upper panel) correlates well with fat stainings (rϭ0.740, PϽ0.0001) or CD68 stainings (rϭ0.740, PϽ0.0001). 14 C-FDG uptake (lower panel) correlated less with fat (0.236, Pϭ0.29) or CD68 staining (0.352, Pϭ0.11). Each white circle (nϭ22) refers to a single autoradiographic signal and its corresponding fat or CD68 staining. hours after 18 F-FDG injection was identified as the optimal time point for visualizing human vulnerable plaques via PET-CT, 8 we also investigated ex vivo imaging of murine plaques 3 hours after 18 F-FDG administration. Our macroscopic en face measurements demonstrated that uptake of FCH visualizes murine plaques more specifically than FDG 20 minutes or 3 hours after radiotracer injection. In particular, the sensitivity for detecting plaques ex vivo was best for 18 F-FCH, lower for 18 F-FDG at 20 minutes, and lowest 3 hours after 18 F-FDG at injection. In addition, our histological analyses revealed that 18 F-FCH uptake correlated significantly with fat and macrophage stainings better than the corresponding correlations of 14 C-FDG uptake. These macroautoradiographic and microautoradiographic findings suggest that FCH may even be better than FDG for visualizing murine plaques ex vivo and render 18 F-FCH a promising candidate for noninvasive imaging of plaque metabolism.
To be applicable for noninvasive plaque imaging, the radiolabeled particles not only have to accumulate within the target tissue, they also have to be cleared quickly from the circulating blood to provide a sufficient signal-to-noise ratio for scintigraphy or PET imaging. For this purpose, 18 F-FCH appears a suitable and promising tool given its rapid blood clearance rate. 23 However, our 18 F-FCH PET scans of ApoE Ϫ/Ϫ mice did not allow us to detect a plaque-specific signal. We think that this was caused by: (1) the difficulty to relate the PET signal to a specific anatomic structure; (2) the limited spatial resolution of small animal PET (Ϸ1 mm) to detect even smaller murine plaques (Ϸ200 to 500 m); (3) the unspecific uptake of 18 F-FCH in metabolically active tissues such as liver and heart; and (4) the moderate SUV of 18 F-FCH as suggested by our experiments. However, we speculate that human plaque imaging using 18 F-FCH is feasible because of: (1) the opportunity to create hybrid images by combining high spatial resolution morphological imaging using CT or MRI with PET; (2) the considerably bigger size of human compared with murine plaques; (3) the similar SUV for 18 F-FDG and 18 F-FCH; and (4) the feasibility of human plaque imaging using 18 F-FDG. 8 Radiolabeled choline is known as a proliferation marker and has been used for imaging brain and prostate cancer. 14, 15 The increased choline uptake in highly proliferative cells such as tumor cells has been related to an upregulation of choline kinase as well as an increased activity of cholinespecific transporters. 19, 24 We show similar levels of choline kinase expression and activity in normal and atherosclerotic murine aortae. Thus, enhanced 18 F-FCH uptake in activated murine plaque macrophages is not caused by changes in choline kinase, but rather by increased choline transport. The rapid uptake (within 30 minutes) of 18 F-FCH into prostate cancer 14, 15 or inflammatory tissues 20 supports this notion. Interestingly, choline and FCH are trapped in the cells, whereas the nonmetabolizable choline analogue 18 Fdeshydroxy-FCH, which also uses the specific transport system, is weakly incorporated in the cells. 24 Thus, accumulation of FCH 20 minutes after injection in our study suggests a specific uptake, because nonspecific transport would not lead to intracellular radiotracer accumulation.
Other radionuclide-based approaches for imaging plaque biology have been reported using radiotracers such as technetium ( 99m Tc)-linked, Indium ( 111 In)-linked, or iodine ( 125 I, 131 I)-linked compounds. 7 Many of the previous studies used macrophage labeling to characterize one important aspect of plaque vulnerability. 25 For example, 99m Tclabeled Annexin V visualized apoptotic macrophages in plaques of atherosclerotic rabbits 26 and in a small number of patients. 27 Similarly, uptake of 125 I-linked monocyte chemoattractant protein 1 (MCP-1) revealed an excellent correlation with macrophages in aortic plaques of atherosclerotic rabbits. 28 Schäfers et al recently reported on scintigraphic imaging of matrix metalloproteinase (MMP) activity in ligation-induced and cholesterol-induced carotid lesions of ApoE Ϫ/Ϫ mice using a 123 l-labeled MMP inhibitor. 29 Similar to our results, the radiotracer signal in these lesions colocalized with activated macrophages. However, the impact of these findings with regard to imaging of murine atherosclerotic plaques has to be interpreted with caution as the type of lesions after complete carotid ligation 30 is different from atherosclerotic plaques in terms of pathophysiology, cellular contents, and size.
Overall, given its limited spatial resolution, scintigraphic imaging using single-photon emission CT (SPECT) may severely limit the detection of small plaques. When compared with SPECT, PET is superior in terms of image resolution (4 mm versus 10 mm) and sensitivity. Although even PETbased devices do not have the spatial resolution to provide detailed tissue characterization, the lesions can be detected if there is a sufficiently high target-to-background ratio. Furthermore, the limited spatial resolution can be addressed by hybrid imaging, which combines radionuclide-based visualization of plaque biology with imaging modalities that provide better anatomic detail such as multislice CT 2 or MRI. 31 For example, PET-CT has been applied successfully at our institution for staging lung cancer 32 or assessing myocardial perfusion. 33 As mentioned, PET-CT has also been used for imaging plaque metabolism using 18 F-FDG. 8 Unfortunately, FDG and FCH are taken up into other metabolically active tissues such as myocardium or liver, a problem that currently excludes its use for imaging coronary atherosclerosis. Finally, the advent of catheter-based devices may provide an attractive tool for invasive detection of plaques. 34 The proximity of the ␤-probe close to the target is likely to improve the detection of plaque-associated radioactive signals. Combining this approach with high-resolution morphological imaging such as OCT 4 would offer an attractive technique for detailed imaging of plaque biology.
In conclusion, our findings characterize 18 F-FCH as a novel agent for imaging relevant aspects of plaque biology. Its colocalization with plaque macrophages may render it an additional marker of vascular inflammation suggesting vulnerability of an atherosclerotic plaque. Its favorable pharmacokinetics with rapid blood clearance as well as the opportunity to visualize 18 F-FCH noninvasively by PET-CT may render this approach an attractive tool for risk stratification of atherosclerotic lesions in patients.
